NOTCH1 and nonpapillary renal cell carcinoma: Subsequently, ccRCC cells were treated with the HDAC10 inhibitor Quisinostat, and the expression of downstream proteins in the Notch-1 signaling pathway and PTEN-related proteins was assessed by Western blotting.